Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
c.9253-6T>c REV3L: A novel marker of poor prognosis in Myelodysplastic syndrome
Roberta Taiane G. de Oliveira; Ivo Gabriel. F. França; Howard L.R. Junior; Giovanna B.C. Riello; Daniela de Paula Borges; Gabrielle Melo Cavalcante; Silvia M.M. Magalhães; Ronald F. Pinheiro;
Hematol Transfus Cell Ther. 2021;43:377-81
Functional polymorphisms of DNA repair genes in Latin America reinforces the heterogeneity of Myelodysplastic Syndrome
Daniela de Paula Borges; Rinna Maria Arruda Rodrigues dos Santos; Elvira Rodrigues Pereira Velloso; Howard Lopes Ribeiro Junior; Irene Beatriz Larripa; Maria Fernanda Camacho; Jacqueline González; Leandro Daniel Burgos Pratx; Sílvia Maria Meira Magalhães; Carolina Bárbara Belli; Ronald Feitosa Pinheiro;
Hematol Transfus Cell Ther. 2023;45:147-53
A HEMATOLOGICAL CHAMELEON: THE TRANSITION FROM MDS TO NON-SECRETORY MULTIPLE MYELOMA AND BACK ¿ UNRAVEL¿NG DIAGNOSTIC COMPLEXITIES AND ADAPTING THERAPEUTIC PATHWAYS
Canda¿ Mumcu; Ceren K¿sa; Birol Güvenç;
Hematol Transfus Cell Ther. 2024;46 Supl 7:S39-40